Vedran Tomašić

5PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2026
Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation.

Zeljka Belosic Halle, Vedran Tomasic, Alen Biscanin

|Nov 27, 2025
Fecal Microbiota Transplantation in Refractory Immune-Mediated Colitis: Case Series and Review of the Literature.

Marin Golčić, Laura Radoš, Iva Skočilić

|Jul 29, 2025
Impaired Quality of Life in Croatian IBD Patients in the Era of Advanced Treatment Options.

Alen Bišćanin, Leon Palac, Zdravko Dorosulić

|Apr 03, 2025
Seeing Is Believing: Does Red Dichromatic Imaging (RDI) Predict Histological Remission and Clinical Outcomes in Ulcerative Colitis Patients?

Vedran Tomašić

|Oct 08, 2021
Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy.

Marijana Miler, Nora Nikolac Gabaj, Ivana Ćelap

Pageof 1

Frequent Collaborators

3 joint publications

Alen Bišćanin

2 joint publications

Irena Krznarić Zrnić

2 joint publications

Marin Golčić

2 joint publications

Petra Ćaćić